Department of Chemical Engineering and Biotechnology, University of Applied Sciences of Darmstadt, Darmstadt, Germany.
Antimicrob Agents Chemother. 2013 Jul;57(7):3388-91. doi: 10.1128/AAC.00129-13. Epub 2013 Apr 15.
A novel papain inhibitory protein (SPI) from Streptomyces mobaraensis was studied to measure its inhibitory effect on bacterial cysteine protease activity (Staphylococcus aureus SspB) and culture supernatants (Porphyromonas gingivalis, Bacillus anthracis). Further, growth of Bacillus anthracis, Staphylococcus aureus, Pseudomonas aeruginosa, and Vibrio cholerae was completely inhibited by 10 μM SPI. At this concentration of SPI, no cytotoxicity was observed. We conclude that SPI inhibits bacterial virulence factors and has the potential to become a novel therapeutic treatment against a range of unrelated pathogenic bacteria.
一种新型木瓜蛋白酶抑制蛋白(SPI)来自藤黄微球菌,研究其对细菌半胱氨酸蛋白酶活性(金黄色葡萄球菌 SspB)和培养上清液(牙龈卟啉单胞菌、炭疽芽孢杆菌)的抑制作用。此外,10μM SPI 完全抑制炭疽芽孢杆菌、金黄色葡萄球菌、铜绿假单胞菌和霍乱弧菌的生长。在 SPI 的这个浓度下,没有观察到细胞毒性。我们得出结论,SPI 抑制细菌毒力因子,并有潜力成为一种针对一系列无关致病菌的新型治疗方法。